Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Liberopoulos

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Hippokratia|July 16, 2016
No effect of switching to high-dose rosuvastatin, add-on nicotinic acid, or add-on fenofibrate on serum vitamin D levels in patients with mixed dyslipidemiaE S Makariou, M Elisaf, A Kei, et al.
Hippokratia|October 1, 2016
Proton pump inhibitors and statins: a possible interaction that favors low-density lipoprotein cholesterol reduction?F Barkas, M Elisaf, C V Rizos, et al.
International Journal of Clinical Practice|October 15, 2011
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistanceE Moutzouri, E Liberopoulos, D P Mikhailidis, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|September 20, 2023
Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS studyC Vlachopoulos, D Massia, G Kochiadakis, et al.
Atherosclerosis Plus|March 1, 2024
Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023N Katsiki, Td Filippatos, C Vlachopoulos, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Hippokratia|July 16, 2016
No effect of switching to high-dose rosuvastatin, add-on nicotinic acid, or add-on fenofibrate on serum vitamin D levels in patients with mixed dyslipidemiaE S Makariou, M Elisaf, A Kei, et al.
Hippokratia|October 1, 2016
Proton pump inhibitors and statins: a possible interaction that favors low-density lipoprotein cholesterol reduction?F Barkas, M Elisaf, C V Rizos, et al.
International Journal of Clinical Practice|October 15, 2011
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistanceE Moutzouri, E Liberopoulos, D P Mikhailidis, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|September 20, 2023
Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS studyC Vlachopoulos, D Massia, G Kochiadakis, et al.
Atherosclerosis Plus|March 1, 2024
Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023N Katsiki, Td Filippatos, C Vlachopoulos, et al.
Pageof 2